Akebia Therapeutics, Inc. (AKBA) Merger & Acquisition Call - Transcript [Seeking Alpha]
Akebia Therapeutics, Inc. (AKBA)
Last akebia therapeutics, inc. earnings: 3/10 07:49 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.akebia.com/investor-relations
Company Research
Source: Seeking Alpha
Akebia Therapeutics, Inc. (NASDAQ: AKBA ) Merger & Acquisition Call June 28, 2018 8:00 AM ET Executives Amy Sullivan - Senior Vice President, Corporate Affairs John Butler - President and Chief Executive Officer, Akebia Therapeutics Jodie Morrison - Interim Chief Executive Officer, Keryx Biopharmaceuticals Jason Amello - Senior Vice President and Chief Financial Officer, Akebia Therapeutics Scott Holmes - Senior Vice President and Chief Financial Officer, Keryx Biopharmaceuticals Analysts Maurice Choy - RBC Capital Markets Bin Lu - Raymond James Bert Hazlett - BTIG Yigal Nochomovitz - Citi Group Alex Bouilloux - Mizuho Securities Jason Kolbert - H.C. Wainwright Ed Arce - H.C. Wainwright Matt Kaplan - Ladenburg Thalmann Operator Good day ladies and gentlemen, and welcome to the Akebia Therapeutics and Keryx Biopharmaceuticals Joint Corporate Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] As
Show less
Read more
Impact Snapshot
Event Time:
AKBA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AKBA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AKBA alerts
High impacting Akebia Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
AKBA
News
- FDA Approves For Akebia Therapeutics' Vafseo For Kidney Disease Associated Anemia [Yahoo! Finance]Yahoo! Finance
- CNN values your feedback [CNN]CNN
- Thinking about buying stock in Ocugen, Akebia Therapeutics, Mind Medicine, SoundHound AI, or Canopy Growth?PR Newswire
- Stocks Set To Close Blowout Week, Month And Quarter At All-Time High; Gold Soars To Record [zero hedge]zero hedge
- Akebia (AKBA) Up as Vafseo Gets FDA Nod for Anemia Due to CKD [Yahoo! Finance]Yahoo! Finance
AKBA
Earnings
- 3/14/24 - Beat
AKBA
Sec Filings
- 3/28/24 - Form 8-K
- 3/15/24 - Form 8-K
- 3/14/24 - Form 10-K
- AKBA's page on the SEC website